COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 2260: Articles 22591-22600  | Next

Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison
Galani, I. E., Rovina, N., Lampropoulou, V., Triantafyllia, V., Manioudaki, M., Pavlos, E., Koukaki, E., Fragkou, P. C., Panou, V., Rapti, V., Koltsida, O., Mentis, A., Koulouris, N., Tsiodras, S., Koutsoukou, A., Andreakos, E.
10.1101/2020.08.21.20179291 — Posted: 2020-08-24
Detection of SARS-CoV-2 using non-commercial RT-LAMP regents and raw samples.
Alekseenko, A., Barrett, D., Pareja-Sanchez, Y., Howard, R., Strandback, E., Ampah-Korsah, H., Rovsnik, U., Zuniga-Veliz, S., Klenov, A., Malloo, J., Ye, S., Liu, X., Reinius, B., Elsässer, S., Nyman, T., Sandh, G., Yin, X., Pelechano, V.
10.1101/2020.08.22.20179507 — Posted: 2020-08-24
Next generation sequencing of SARS-CoV-2 from patient specimens of Nevada reveals occurrence of specific nucleotide variants at high frequency
Hartley, P., Tillett, R. L., Xu, Y., AuCoin, D. P., Sevinsky, J. R., Gorzalski, A., PANDORI, M. C., Rossetto, C. C., Verma, S.
10.1101/2020.08.21.20178863 — Posted: 2020-08-24
Prevalence and outcome of Covid-19 infection in cancer patients: a national VA study
Fillmore, N. R., La, J., Szalat, R. E., Tuck, D. P., Nguyen, V., Yildirim, C., Do, N. V., Brophy, M. T., Munshi, N. C.
10.1101/2020.08.21.20177923 — Posted: 2020-08-24
Platelet-to-lymphocyte ratio (PLR), a novel biomarker to predict the severity of COVID-19 patients: a systematic review and meta-analysis
Simadibrata, D. M., Pandhita, B. A. W., Ananta, M. E., Tango, T.
10.1101/2020.08.21.20166355 — Posted: 2020-08-24
Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility
van Blokland, I. V., Lanting, P., Ori, A. P., Vonk, J. M., Warmerdam, R. C., Herkert, J. C., Boulogne, F., Claringbould, A., Lopera-Maya, E. A., Bartels, M., Hottenga, J.-J., Ganna, A., Karjalainen, J., Lifelines COVID-19 cohort study, , The COVID-19 Host Genetics Initiative, , Hayward, C., Fawns-Ritchie, C., Campbell, A., Porteous, D., Cirulli, E. T., Schiabor Barrett, K. M., Riffle, S., Bolze, A., White, S., Tanudjaja, F., Wang, X., Ramirez, J. M., Lim, Y. W., Lu, J. T., Washington, N. L., de Geus, E. J., Deelen, P., Boezen, H. M., Franke, L. H.
10.1101/2020.08.21.20177246 — Posted: 2020-08-24
SARS-CoV-2 infection and transmission in educational settings: cross-sectional analysis of clusters and outbreaks in England
Ismail, S. A., Saliba, V., Lopez Bernal, J. A., Ramsay, M. E., Ladhani, S. N.
10.1101/2020.08.21.20178574 — Posted: 2020-08-24 Discussion: Onsite
Health Disparities and COVID-19: A Retrospective Study Examining Individual and Community Factors Causing Disproportionate COVID-19 Outcomes in Cook County, Illinois, March 16-May 31, 2020
Unruh, L., Dharmapuri, S., Yinglin, X., Soyemi, K.
10.1101/2020.08.21.20179317 — Posted: 2020-08-24 Discussion: Offsite
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Tani, H., Tan, L., Kimura, M., Yoshida, Y., Yamada, H., Fukushi, S., Saijo, M., Kawasuji, H., Ueno, A., Miyajima, Y., Fukui, Y., Sakamaki, I., Yamamoto, Y., Morinaga, Y.
10.1101/2020.08.21.262295 — Posted: 2020-08-23
Lipid droplets fuels SARS-CoV-2 replication and inflammatory response
Gomes Dias, S. S., Cardoso, V. S., Ferreira, A. C., Sacramento, C. Q., Fintelman-Rodrigues, N., Temerozo, J. R., Teixeira, L., Barreto, E. A., Mattos, M., de Freitas, C. S., Azevedo-Quintanilha, I., Manso, P. P. A., Hottz, E. D., Pao, C. R. R., Bou-Habib, D. C., Bozza, F. A., Souza, T. M. L., Bozza, P. T.
10.1101/2020.08.22.262733 — Posted: 2020-08-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).